Ablative therapy in ARVD and Brugada Syndrome: Is there a role?


Dr Daljeet Kaur Saggu, Hyderabad    30 November 2017

Catheter ablation is feasible in patients with both ARVD and Brugada syndrome who have recurrent ICD shocks secondary to refractory VT. Substrate based ablation can be performed in both ARVD and Brugada syndrome without the need to induce unstable ventricular tachycardia in the Electrophysiology lab EP . Epicardial ablation along with endocardial ablation is frequently required in both these entities. In Brugada syndrome sodium channel blocker procainamide flecainide can be used to unmask abnormal areas in some patients. Triggering PVCs if present in the EP lab can be targeted for ablation.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.